Novel Therapies for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.6, 2008-01, pp. : 747-770

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mouse Models of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Current Pharmaceutical Design, Vol. 21, Iss. 18, 2015-06 ,pp. : 2380-2390

Bentham Science Publishers

Access to resources Recommend Favorite

Hydroxycarbamide: Anti-neutrophil cytoplasmic antibody-associated vasculitis (first report) in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1385, 2012-01 ,pp. : 22-23

Adis International

Access to resources Recommend Favorite

Antineutrophil Cytoplasmic Antibody-Positive Vasculitis Associated with Propylthiouracil Therapy

By Dinmezel S. Ogus C. özdemir T.

Clinical Drug Investigation, Vol. 23, Iss. 12, 2003-01 ,pp. : 817-821

Adis International

Access to resources Recommend Favorite

Propylthiouracil: Anti-neutrophil cytoplasmic antibody-positive vasculitis in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1422, 2012-01 ,pp. : 41-41

Adis International

Access to resources Recommend Favorite

Mycophenolate mofetil (MMF) effectively treats antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV)

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite